These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 34147723)

  • 1. Targeting the tumor microenvironment with amphiphilic near-infrared cyanine nanoparticles for potentiated photothermal immunotherapy.
    Noh I; Son Y; Jung W; Kim M; Kim D; Shin H; Kim YC; Jon S
    Biomaterials; 2021 Aug; 275():120926. PubMed ID: 34147723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional nanoparticles precisely reprogram the tumor microenvironment and potentiate antitumor immunotherapy after near-infrared-II light-mediated photothermal therapy.
    Ge Y; Zhang J; Jin K; Ye Z; Wang W; Zhou Z; Ye J
    Acta Biomater; 2023 Sep; 167():551-563. PubMed ID: 37302731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polydopamine-based nanoplatform for photothermal ablation with long-term immune activation against melanoma and its recurrence.
    Li M; Guo R; Wei J; Deng M; Li J; Tao Y; Li M; He Q
    Acta Biomater; 2021 Dec; 136():546-557. PubMed ID: 34536603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photothermally activatable PDA immune nanomedicine combined with PD-L1 checkpoint blockade for antimetastatic cancer photoimmunotherapy.
    Lu Q; Qi S; Li P; Yang L; Yang S; Wang Y; Cheng Y; Song Y; Wang S; Tan F; Li N
    J Mater Chem B; 2019 Apr; 7(15):2499-2511. PubMed ID: 32255127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Black porous silicon as a photothermal agent and immunoadjuvant for efficient antitumor immunotherapy.
    Xu W; Pang C; Song C; Qian J; Feola S; Cerullo V; Fan L; Yu H; Lehto VP
    Acta Biomater; 2022 Oct; 152():473-483. PubMed ID: 36087872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quercetin-ferrum nanoparticles enhance photothermal therapy by modulating the tumor immunosuppressive microenvironment.
    Li L; Zhang M; Liu T; Li J; Sun S; Chen J; Liu Z; Zhang Z; Zhang L
    Acta Biomater; 2022 Dec; 154():454-466. PubMed ID: 36243377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-delivery of metal-coordinated NIR-II nanoadjuvants for multimodal imaging-guided photothermal-chemodynamic amplified immunotherapy.
    Dai Y; Li X; Xue Y; Chen K; Jiao G; Zhu L; Li M; Fan Q; Dai Y; Zhao Q; Shen Q
    Acta Biomater; 2023 Aug; 166():496-511. PubMed ID: 37230439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Endogenous Vaccine Based on Fluorophores and Multivalent Immunoadjuvants Regulates Tumor Micro-Environment for Synergistic Photothermal and Immunotherapy.
    Li L; Yang S; Song L; Zeng Y; He T; Wang N; Yu C; Yin T; Liu L; Wei X; Wu Q; Wei Y; Yang L; Gong C
    Theranostics; 2018; 8(3):860-873. PubMed ID: 29344312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A biomimetic nanoplatform for precise reprogramming of tumor-associated macrophages and NIR-II mediated antitumor immune activation.
    Du Y; Qian X; Lin F; Gao B; Wang W; Yang H; Wang W; Ding Y
    Acta Biomater; 2023 May; 162():85-97. PubMed ID: 36948328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supramolecular Photothermal Nanomedicine Mediated Distant Tumor Inhibition via PD-1 and TIM-3 Blockage.
    Huang TY; Huang GL; Zhang CY; Zhuang BW; Liu BX; Su LY; Ye JY; Xu M; Kuang M; Xie XY
    Front Chem; 2020; 8():1. PubMed ID: 32117862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Immunosuppressive Microenvironment in Acquiring Immunotolerance Post-Photothermal Therapy.
    Cherukula K; Park MS; Sontyana AG; Mathew AP; Vijayan V; Bae WK; Park IK
    J Korean Med Sci; 2019 Nov; 34(44):e272. PubMed ID: 31726492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclodextrin-Functionalized Gold Nanorods Loaded with Meclofenamic Acid for Improving
    Liu J; Song Y; Wang Y; Han M; Wang C; Yan F
    ACS Appl Mater Interfaces; 2022 Sep; 14(36):40612-40623. PubMed ID: 36053499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining photothermal therapy and immunotherapy against melanoma by polydopamine-coated Al
    Chen W; Qin M; Chen X; Wang Q; Zhang Z; Sun X
    Theranostics; 2018; 8(8):2229-2241. PubMed ID: 29721075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanocodelivery of an NIR photothermal agent and an acid-responsive TLR7 agonist prodrug to enhance cancer photothermal immunotherapy and the abscopal effect.
    Chen B; Huang R; Zeng W; Wang W; Min Y
    Biomaterials; 2024 Mar; 305():122434. PubMed ID: 38141501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photothermally sensitive gold nanocage augments the antitumor efficiency of immune checkpoint blockade in immune "cold" tumors.
    Xiao G; Zhao Y; Wang X; Zeng C; Luo F; Jing J
    Front Immunol; 2023; 14():1279221. PubMed ID: 37942337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer.
    Liu H; Xu C; Meng M; Li S; Sheng S; Zhang S; Ni W; Tian H; Wang Q
    Acta Biomater; 2022 May; 144():132-141. PubMed ID: 35307591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic-responsive and targeted cancer nanotheranostics by PA/MR bimodal imaging-guided photothermally triggered immunotherapy.
    Guo Y; Ran Y; Wang Z; Cheng J; Cao Y; Yang C; Liu F; Ran H
    Biomaterials; 2019 Oct; 219():119370. PubMed ID: 31357006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of NIR therapy and regulatory T cell modulation using layer-by-layer hybrid nanoparticles for effective cancer photoimmunotherapy.
    Ou W; Jiang L; Thapa RK; Soe ZC; Poudel K; Chang JH; Ku SK; Choi HG; Yong CS; Kim JO
    Theranostics; 2018; 8(17):4574-4590. PubMed ID: 30279723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic triple-combination therapy with hyaluronic acid-shelled PPy/CPT nanoparticles results in tumor regression and prevents tumor recurrence and metastasis in 4T1 breast cancer.
    Sun W; Du Y; Liang X; Yu C; Fang J; Lu W; Guo X; Tian J; Jin Y; Zheng J
    Biomaterials; 2019 Oct; 217():119264. PubMed ID: 31260883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted NIR-responsive theranostic immuno-nanomedicine combined TLR7 agonist with immune checkpoint blockade for effective cancer photothermal immunotherapy.
    Yasothamani V; Vivek R
    J Mater Chem B; 2022 Aug; 10(33):6392-6403. PubMed ID: 35971846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.